DR Horton Inc (DHI)

Return on equity (ROE)

		Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Net income	US$ in thousands	4,756,400	4,745,700	5,857,500	4,175,800	2,373,700
Total stockholders’ equity	US$ in thousands	25,312,800	22,696,200	19,396,300	14,886,500	11,840,000
ROE		18.79%	20.91%	30.20%	28.05%	20.05%

September 30, 2024 calculation

ROE = Net income ÷ Total stockholders’ equity
= $4,756,400K ÷ $25,312,800K
= 18.79%

DR Horton Inc's return on equity (ROE) has shown fluctuations over the past five years, with the ROE decreasing from 30.20% in 2022 to 18.79% in 2024. This downward trend indicates a reduction in the company's ability to generate profits from shareholders' equity during this period. However, it is important to note that the ROE levels are still relatively healthy, indicating that the company is utilizing its equity effectively to generate returns for shareholders. The ROE peaked at 30.20% in 2022, suggesting a strong performance in that year. Overall, DR Horton Inc's ROE performance should be further analyzed in conjunction with other financial metrics to gain a comprehensive understanding of the company's financial health and operational efficiency.